Medicare-Paid Naloxone: Trends in Non-Metropolitan and Metropolitan Areas

Chris Delcher; Yue Cheng; Minji Sohn; Jeffery C. Talbert; Jeffery C. Talbert; Patricia R. Freeman

Medicare-Paid Naloxone: Trends in Non-Metropolitan and Metropolitan Areas

Chris Delcher
, Yue Cheng
, Minji Sohn
, Jeffery C. Talbert
, Jeffery C. Talbert
, Patricia R. Freeman

Research output: Other contribution

Abstract

Overview of Key Findings

Medicare pays for the largest share (> 30%) of naloxone dispensed from retail pharmacies in non-metropolitan areas.Medicare-paid dispensing has grown since 2013, but from 2017-2018 dispensing growth in non-metropolitan areas slowed considerably compared to metropolitan areas (42% v 121%, respectively).As of 2018, the rate of naloxone dispensing to Medicare enrollees in metropolitan areas was approximately double that in non-metropolitan areas (4.9 v 2.9 per 1,000 enrollees, respectively).

Original language	American English
State	Published - May 1 2021

Access to Document

https://uknowledge.uky.edu/context/ruhrc_reports/article/1017/viewcontent

Cite this

@misc{8d5b23a7ad7949a6bd621f515f216479,

title = "Medicare-Paid Naloxone: Trends in Non-Metropolitan and Metropolitan Areas",

abstract = "Overview of Key Findings Medicare pays for the largest share (> 30\%) of naloxone dispensed from retail pharmacies in non-metropolitan areas.Medicare-paid dispensing has grown since 2013, but from 2017-2018 dispensing growth in non-metropolitan areas slowed considerably compared to metropolitan areas (42\% v 121\%, respectively).As of 2018, the rate of naloxone dispensing to Medicare enrollees in metropolitan areas was approximately double that in non-metropolitan areas (4.9 v 2.9 per 1,000 enrollees, respectively). ",

author = "Chris Delcher and Yue Cheng and Minji Sohn and Talbert, \{Jeffery C.\} and Talbert, \{Jeffery C.\} and Freeman, \{Patricia R.\}",

year = "2021",

month = may,

day = "1",

language = "American English",

type = "Other",

}

TY - GEN

T1 - Medicare-Paid Naloxone: Trends in Non-Metropolitan and Metropolitan Areas

AU - Delcher, Chris

AU - Cheng, Yue

AU - Sohn, Minji

AU - Talbert, Jeffery C.

AU - Freeman, Patricia R.

PY - 2021/5/1

Y1 - 2021/5/1

N2 - Overview of Key Findings Medicare pays for the largest share (> 30%) of naloxone dispensed from retail pharmacies in non-metropolitan areas.Medicare-paid dispensing has grown since 2013, but from 2017-2018 dispensing growth in non-metropolitan areas slowed considerably compared to metropolitan areas (42% v 121%, respectively).As of 2018, the rate of naloxone dispensing to Medicare enrollees in metropolitan areas was approximately double that in non-metropolitan areas (4.9 v 2.9 per 1,000 enrollees, respectively).

AB - Overview of Key Findings Medicare pays for the largest share (> 30%) of naloxone dispensed from retail pharmacies in non-metropolitan areas.Medicare-paid dispensing has grown since 2013, but from 2017-2018 dispensing growth in non-metropolitan areas slowed considerably compared to metropolitan areas (42% v 121%, respectively).As of 2018, the rate of naloxone dispensing to Medicare enrollees in metropolitan areas was approximately double that in non-metropolitan areas (4.9 v 2.9 per 1,000 enrollees, respectively).

M3 - Other contribution

ER -

Medicare-Paid Naloxone: Trends in Non-Metropolitan and Metropolitan Areas

Abstract

Access to Document

Fingerprint

Cite this